Annual SG&A
$466.84 M
-$35.58 M-7.08%
31 December 2023
Summary:
GoodRx Holdings annual selling, general & administrative expenses is currently $466.84 million, with the most recent change of -$35.58 million (-7.08%) on 31 December 2023. During the last 3 years, it has fallen by -$249.74 million (-34.85%). GDRX annual SG&A is now -34.85% below its all-time high of $716.59 million, reached on 31 December 2020.GDRX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$115.49 M
-$5.56 M-4.59%
30 September 2024
Summary:
GoodRx Holdings quarterly selling, general & administrative expenses is currently $115.49 million, with the most recent change of -$5.56 million (-4.59%) on 30 September 2024. Over the past year, it has dropped by -$11.45 million (-9.02%). GDRX quarterly SG&A is now -72.22% below its all-time high of $415.69 million, reached on 31 December 2020.GDRX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$5.82 B
-$16.22 M-0.28%
30 September 2024
Summary:
GoodRx Holdings TTM selling, general & administrative expenses is currently -$5.82 billion, with the most recent change of -$16.22 million (-0.28%) on 30 September 2024. Over the past year, it has dropped by -$6.27 billion (-1376.88%). GDRX TTM SG&A is now -430.19% below its all-time high of $840.73 million, reached on 30 June 2021.GDRX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GDRX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.1% | -9.0% | -1376.9% |
| 3 y3 years | -34.9% | -12.2% | -828.1% |
| 5 y5 years | +314.8% | +135.4% | -10000.0% |
GDRX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -34.9% | at low | -18.6% | +7.3% | -5.5% | at low |
| 5 y | 5 years | -34.9% | +314.8% | -72.2% | +135.4% | -430.2% | at low |
| alltime | all time | -34.9% | +314.8% | -72.2% | +135.4% | -430.2% | at low |
GoodRx Holdings Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $115.49 M(-4.6%) | $491.72 M(-2.3%) |
| June 2024 | - | $121.04 M(-7.7%) | $503.17 M(+2.7%) |
| Mar 2024 | - | $131.07 M(+5.6%) | $489.77 M(+4.9%) |
| Dec 2023 | $466.84 M(-7.1%) | $124.12 M(-2.2%) | $466.84 M(+2.5%) |
| Sept 2023 | - | $126.93 M(+17.9%) | $455.43 M(-1.9%) |
| June 2023 | - | $107.65 M(-0.5%) | $464.26 M(-4.4%) |
| Mar 2023 | - | $108.14 M(-4.1%) | $485.69 M(-3.3%) |
| Dec 2022 | $502.42 M(-4.3%) | $112.71 M(-17.0%) | $502.42 M(-5.5%) |
| Sept 2022 | - | $135.76 M(+5.2%) | $531.58 M(+0.8%) |
| June 2022 | - | $129.08 M(+3.4%) | $527.41 M(+0.2%) |
| Mar 2022 | - | $124.87 M(-12.0%) | $526.30 M(+0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $524.90 M(-26.7%) | $141.87 M(+7.8%) | $524.90 M(-34.3%) |
| Sept 2021 | - | $131.60 M(+2.8%) | $798.73 M(-5.0%) |
| June 2021 | - | $127.96 M(+3.6%) | $840.73 M(+9.0%) |
| Mar 2021 | - | $123.48 M(-70.3%) | $771.02 M(+7.6%) |
| Dec 2020 | $716.59 M(+273.9%) | $415.69 M(+139.5%) | $716.59 M(+99.2%) |
| Sept 2020 | - | $173.59 M(+198.0%) | $359.75 M(+52.9%) |
| June 2020 | - | $58.25 M(-15.6%) | $235.21 M(+32.9%) |
| Mar 2020 | - | $69.05 M(+17.3%) | $176.96 M(+64.0%) |
| Dec 2019 | $191.66 M(+70.3%) | $58.85 M(+20.0%) | $107.91 M(+120.0%) |
| Sept 2019 | - | $49.05 M | $49.05 M |
| Dec 2018 | $112.54 M | - | - |
FAQ
- What is GoodRx Holdings annual selling, general & administrative expenses?
- What is the all time high annual SG&A for GoodRx Holdings?
- What is GoodRx Holdings annual SG&A year-on-year change?
- What is GoodRx Holdings quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for GoodRx Holdings?
- What is GoodRx Holdings quarterly SG&A year-on-year change?
- What is GoodRx Holdings TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for GoodRx Holdings?
- What is GoodRx Holdings TTM SG&A year-on-year change?
What is GoodRx Holdings annual selling, general & administrative expenses?
The current annual SG&A of GDRX is $466.84 M
What is the all time high annual SG&A for GoodRx Holdings?
GoodRx Holdings all-time high annual selling, general & administrative expenses is $716.59 M
What is GoodRx Holdings annual SG&A year-on-year change?
Over the past year, GDRX annual selling, general & administrative expenses has changed by -$35.58 M (-7.08%)
What is GoodRx Holdings quarterly selling, general & administrative expenses?
The current quarterly SG&A of GDRX is $115.49 M
What is the all time high quarterly SG&A for GoodRx Holdings?
GoodRx Holdings all-time high quarterly selling, general & administrative expenses is $415.69 M
What is GoodRx Holdings quarterly SG&A year-on-year change?
Over the past year, GDRX quarterly selling, general & administrative expenses has changed by -$11.45 M (-9.02%)
What is GoodRx Holdings TTM selling, general & administrative expenses?
The current TTM SG&A of GDRX is -$5.82 B
What is the all time high TTM SG&A for GoodRx Holdings?
GoodRx Holdings all-time high TTM selling, general & administrative expenses is $840.73 M
What is GoodRx Holdings TTM SG&A year-on-year change?
Over the past year, GDRX TTM selling, general & administrative expenses has changed by -$6.27 B (-1376.88%)